ストックスクリーナーアプリを入手
65.38
1.72%
-1.0626
Disc Medicine Inc (IRON) 最新ニュース
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Behavioral Patterns of IRON and Institutional Flows - news.stocktradersdaily.com
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - PR Newswire
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Wells Fargo Maintains Disc Medicine(IRON.US) With Buy Rating, Raises Target Price to $86 - moomoo.com
Disc Medicine CEO Quisel John D Exercises Options, Holding 262,064 Shares Post-Transaction - Kalkine Media
Disc Medicine (IRON) Reports Encouraging RESTORE PV Data, Is The Stock Undervalued? - simplywall.st
Disc Medicine (NASDAQ: IRON) CEO turns 36,000 options into stock - Stock Titan
IRON Form 4 FilingsDisc Medicine, Inc. SEC Form 4 - Stock Titan
IRON Maintained by Wells Fargo -- Price Target Raised to $86.00 - GuruFocus
[Form 4] Disc Medicine, Inc. Insider Trading Activity - Stock Titan
Kevin Bitterman Sells 27,136 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Squarepoint Ops LLC Increases Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine (NASDAQ:IRON) Raised to "Hold" at Wall Street Zen - MarketBeat
Officer at Disc Medicine (NASDAQ: IRON) plans to sell 27,136 shares - Stock Titan
Disc Medicine (NASDAQ:IRON) Shares Down 5%Should You Sell? - MarketBeat
The Technical Signals Behind (IRON) That Institutions Follow - Stock Traders Daily
Opaleye Management Inc. Raises Stock Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Shares Polycythemia Vera Data, Outlines Late 2026 Trial Milestones - Benzinga
IRON Reiterated by Wedbush -- Price Target Maintained at $100 - GuruFocus
Disc Medicine's Phase 2 rare blood cancer data; Frazier adds to public fund - Endpoints News
Form 8K Disc Medicine Inc For: 10 September By Investing.com - Investing.com South Africa
Disc Medicine reports promising DISC-3405 Phase 2 data - TipRanks
Disc Medicine's (IRON) "Outperform" Rating Reiterated at Wedbush - MarketBeat
Disc Medicine at Wells Fargo conference: two drug bets near key tests - Investing.com Canada
H.C. Wainwright reiterates Disc Medicine stock rating on trial data By Investing.com - Investing.com India
Disc Medicine reports Phase 2 DISC-3405 trial results - grafa.com
Jefferies reiterates Disc Medicine stock rating on polycythemia data By Investing.com - Investing.com Nigeria
Disc Medicine stock rating held at Outperform by BMO on trial data - Investing.com Canada
Disc Medicine reports positive phase 2 trial results for DISC-3405 By Investing.com - Investing.com South Africa
Disc Medicine (IRON) Reports Promising Phase 2 Data; Market Pric - GuruFocus
Disc Medicine reports positive phase 2 trial results for DISC-3405 - investing.com
Blood-removal procedures fell from 4.0 at baseline to 0.6 after treatment - Stock Titan
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $135,052.44 in Stock - MarketBeat
Disc Medicine (NASDAQ: IRON) director sells shares under preset plan - Stock Titan
Disc Medicine at cantorfitzgerald healthcare conference: pipeline nears key tests - Investing.com Canada
Disc Medicine faces class action over alleged m... - Pluang
Legal & General Group Plc Invests $1.35 Million in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Small Disc Medicine (NASDAQ: IRON) shareholder sale planned - Stock Titan
Disc Medicine (NASDAQ: IRON) files notice to sell about $60K in stock - Stock Titan
Disc Medicine (NASDAQ: IRON) holder plans $72K stock sale - Stock Titan
Proposed $176K Disc Medicine (NASDAQ: IRON) share sale by Atlas Venture Fund X - Stock Titan
Kevin Bitterman Sells 129 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Insider Selling: Disc Medicine (NASDAQ:IRON) Director Sells $3,941,477.88 in Stock - MarketBeat
Kevin Bitterman Sells 5,203 Shares of Disc Medicine (NASDAQ:IRON) Stock - MarketBeat
Disc Medicine (IRON) director's funds sell 54K shares in 10b5-1 trades - Stock Titan
Disc Medicine(IRON.US) Director Sells US$4.37 Million in Common Stock - Moomoo
Atlas fund plans small Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share sale - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans $225K stock sale - Stock Titan
Disc Medicine (IRON) investor plans 2,339-share sale - Stock Titan
Man Group plc Takes $1.09 Million Position in Disc Medicine, Inc. $IRON - MarketBeat
The Manufacturers Life Insurance Company Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Venture fund to sell 513 Disc Medicine (NASDAQ: IRON) shares - Stock Titan
Disc Medicine (NASDAQ: IRON) investor plans Rule 144 share sale - Stock Titan
Venture backer plans Disc Medicine (NASDAQ: IRON) share sale - Stock Titan
Venture fund plans Disc Medicine (IRON) share resale - Stock Titan
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
4.12%
1.09%
大文字化:
|
ボリューム (24 時間):